Innovation and Initiatives Audited


Bioscience Solutions has advanced innovation at our research centers and through a number of initiatives, including specialist conferences and publication of white papers. In June 2017 in Annapolis, MD (USA), Lonza held the Third Annual Global Endotoxin Summit, which brought together experts from around the world to discuss the latest research and market trends.

 

We expanded on-line support with the launch of a new Endothelial Cell Application Center in August 2017. This resource provides educational materials and product information to assist with vital endothelial cell research.

Bioscience Solutions is currently working on a Research & Development project for our second generation of PyroGene™, which is expected to provide a more stable production process and improved product quality.

We opened a new Center of Excellence facility in Durham, NC (USA), for primary-cell manufacturing, as well as for future research and development for cell biology. The transfer of these manufacturing activities from Walkersville to the new facility in Durham will leverage synergies and provide space for our growing endotoxin and media business at the Walkersville site.

This move also will strengthen our market position in cell biology. In turn, our endotoxin-detection portfolio market position will also be strengthened with Walkersville’s renewed focus on the needs of additional manufacturing customers.

Another important initiative is the new West Coast commercial and warehousing office in South San Francisco, CA (USA). This location ensures closer proximity to key pharma and biotech accounts in the area and faster, better service and shipping options for West Coast customers.